Gvs — Capital/Financing Update 2020

Jun 29, 2020

Informazione Regolamentata n. 2251-5-2020		Data/Ora Ricezione 29 Giugno 2020 18:51:32	MTA
Societa'	:	GVS S.P.A.
Identificativo Informazione Regolamentata	:	134389
Nome utilizzatore	:	GVSN02 - Mario Saccone
Tipologia	:	REGEM
Data/Ora Ricezione	:	29 Giugno 2020 18:51:32
Data/Ora Inizio Diffusione presunta	:	29 Giugno 2020 18:51:33
Oggetto	:	GVS S.p.A.: Esercizio dell'opzione greenshoe e termine del periodo di stabilizzazione
Testo del comunicato

Vedi allegato.

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO

Comunicato Stampa

GVS: Esercizio dell'opzione greenshoe e termine del periodo di stabilizzazione

Zola Predosa (BO), 29 giugno 2020 - GVS S.p.A. ("GVS" o la "Società") comunica, sulla base delle informazioni ricevute da Mediobanca - Banca di Credito Finanziario S.p.A. ("Mediobanca") quale soggetto incaricato dell'attività di stabilizzazione sulle azioni ordinarie di GVS (le "Azioni GVS"), che in data 29 giugno 2020 è stata esercitata integralmente (e pertanto per un numero di Azioni GVS pari a 9.000.000 da acquistarsi dall'Azionista Venditore, GVS Group S.p.A.) da parte di Mediobanca, per conto dei joint global coordinators, la c.d. opzione greenshoe. Con l'esercizio dell'opzione greenshoe termina il periodo di stabilizzazione con effetto immediato.

Si ricorda che il prezzo di acquisto delle Azioni GVS oggetto dell'opzione greenshoe è di Euro 8,15 per azione – corrispondente al prezzo d'offerta stabilito nell'ambito del collocamento istituzionale – per un controvalore complessivo pari a Euro 73.350.000, al lordo delle commissioni dell'offerta istituzionale.

Il regolamento dell'opzione greenshoe sarà in data e per valuta 1 luglio 2020.

Incluse le Azioni GVS oggetto dell'opzione greenshoe, il collocamento istituzionale ha riguardato pertanto n. 70.000.000 Azioni GVS, pari al 40,00% del capitale sociale e il 25,00% del capitale sociale della Società avente diritto di voto.

Inoltre, sempre sulla base delle informazioni fornite da Mediobanca e anche per conto della stessa, GVS comunica che durante il periodo di stabilizzazione, dalla data di inizio delle negoziazioni delle Azioni GVS sul Mercato Telematico Azionario organizzato e gestito da Borsa Italiana S.p.A. ("MTA"), ossia il 19 giugno 2020, fino alla data odierna, non è stata effettuata alcuna operazione di stabilizzazione.

***

Nell'ambito dell'offerta, Goldman Sachs International e Mediobanca - Banca di Credito Finanziario S.p.A. hanno agito in qualità di joint global coordinators e joint bookrunners. Mediobanca - Banca di Credito Finanziario S.p.A. ha agito altresì in qualità di Sponsor per l'ammissione a quotazione delle Azioni GVS sul MTA. Lazard ha agito in qualità di advisor finanziario della Società. Alirahealth ha agito in qualità di independent strategic advisor.

White & Case ha agito in qualità di consulente legale della Società, mentre Clifford Chance ha agito in qualità di consulente legale dei joint global coordinators e joint bookrunners. La società incaricata della revisione legale dei conti di GVS è PricewaterhouseCoopers S.p.A..

Il presente comunicato è diffuso anche per conto di Mediobanca - Banca di Credito Finanziario S.p.A. ai sensi dell'art. 8, lettera f) e dell'art. 6, comma 3, e del Regolamento Delegato (UE) 2016/1052 dell'8 marzo 2016.

***

Descrizione del Gruppo GVS

Il Gruppo GVS è tra i leader mondiali nella fornitura di soluzioni filtranti per applicazioni nei settori Healthcare & Life Sciences, Energy & Mobility e Health & Safety.

La forte tendenza all'internazionalizzazione ha portato GVS all'apertura di 13 stabilimenti di produzione situati in Italia, Regno Unito, Brasile, USA, Cina, Messico e Romania, e di 6 uffici commerciali in Russia, Turchia, Argentina, Giappone, Cina e Corea.

Nell'esercizio chiuso al 31 dicembre 2019, il gruppo GVS ha registrato ricavi da contratti con i clienti pari a Euro 227 milioni e un EBITDA Normalizzato pari a Euro 62 milioni.

PER ULTERIORI INFORMAZIONI:

Image Building - Media Relations

gvs@imagebuilding.it

Claudia Caracausi – 338 4476613 | Simona Raffaelli – 335 1245191 | Emilia Pezzini – 331 1787169

***

These materials are not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Canada, Australia and Japan (or in any other jurisdiction where it is unlawful to do so). This communication does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States or in any other jurisdiction. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933 as amended (the "Securities Act"). The securities may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of securities in the United States, Canada, Australia and Japan or in any other jurisdiction where it is unlawful to do so. This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons"). The Shares are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. This document is an advertisement and is not a prospectus for the purposes of the Prospectus Directive. A prospectus prepared pursuant to the Prospectus Directive has been published and an international offering circular has been made available in connection with the Offering described below. Investors should not subscribe for any securities referred to in this document except on the basis of information contained in the prospectus or the international offering circular which include detailed information regarding the Company and the risks involved in investing in the securities. In any EEA Member State that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive. The expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in any relevant Member State) and includes any relevant implementing measure in the relevant Member State. In Canada the Shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the Shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.

This announcement is not a prospectus within the meaning of Directive 2003/71/EC of the European Parliament at the Council of November 4th, 2003, as amended, in particular by Directive 2010/73/UE (together, the "Prospectus Directive").

Investors should not subscribe for any securities referred to in this document except on the basis of information contained in the prospectus or the international offering circular which include detailed information regarding the Company and the risks involved in investing in the securities. In any EEA Member State that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.

The distribution of this press release is not made, and has not been approved, by an "authorized person" within the meaning of Article 21(1) of the Financial Services and Markets Act 2000. As a consequence, this press release is directed only at persons who (i) are located outside the United Kingdom, (ii) have professional experience in matters relating to investments and fall within Article 19(5) ("investment professionals") of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (as amended), (iii) are persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (iv) are persons to whom this press release may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). This press release is not a prospectus which has been approved by the Financial Conduct Authority or any other United Kingdom regulatory authority for the purposes of Section 85 of the Financial Services and Markets Act 2000.

The distribution of this document in certain countries may constitute a breach of applicable law. The information contained in this document does not constitute an offer of securities for sale in Canada, Australia or Japan. This press release may not be published, forwarded or distributed, directly or indirectly, in Canada, Australia or Japan.

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the shares of the Company (the "Shares") have been subject to a product approval process, which has determined that such Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II to such target market (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, distributors should note that: the price of the Shares may decline and investors could lose all or part of their investment; the Shares offer no guaranteed income and no capital protection; and an investment in the Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the offering. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the joint global coordinators and joint bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Shares and determining appropriate distribution channels.

No representation or warranty, express or implied, is made by Goldman Sachs International and Mediobanca – Banca di Credito Finanziario S.p.A. (the "Managers"), or any of their respective affiliates, directors, officers, employees, advisers or agents as to the accuracy or completeness or verification of the information contained in this announcement, and nothing contained herein is, or shall be relied upon as, a promise or representation by the Managers in this respect, whether as to the past or future.

None of the Managers assumes any responsibility for its accuracy, completeness or verification and accordingly the Managers disclaim, to the fullest extent permitted by applicable law, any and all liability whether arising in tort, contract or otherwise which they might otherwise be found to have in respect of this announcement or any such statement.

The Managers are each acting exclusively for the Company and the shareholders selling Shares in the transaction referred to in this announcement and for no-one else in connection with any transaction mentioned in this announcement and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to any such transaction and will not be responsible to any other person for providing the protections afforded to their respective clients, or for advising any such person on the contents of this announcement or in connection with any transaction referred to in this announcement. The contents of this announcement have not been verified by theManagers.